Vaccines to prevent transmission of HIV-1 via breastmilk: scientific and logistical priorities
- 1 August 2006
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 368 (9534) , 511-521
- https://doi.org/10.1016/s0140-6736(06)69159-9
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Mother-to-Child Transmission of HIV Infection in the Era of Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2005
- Use of Antiretroviral Drugs to Prevent HIV-1 Transmission Through Breast-feeding: From Animal Studies to Randomized Clinical TrialsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Advances in the prevention of vertical transmission of human immunodeficiency virusSeminars in Pediatric Infectious Diseases, 2003
- Enhanced: The Need for a Global HIV Vaccine EnterpriseScience, 2003
- Development of Resistance Mutations in Women Receiving Standard Antiretroviral Therapy Who Received Intrapartum Nevirapine to Prevent Perinatal Human Immunodeficiency Virus Type 1 Transmission: A Substudy of Pediatric AIDS Clinical Trials Group Protocol 316The Journal of Infectious Diseases, 2002
- Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 TransmissionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)AIDS, 2001
- Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmissionAIDS, 2000
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994